Shares of Evaxion Biotech A/S (NASDAQ:EVAX) rose sharply in today's pre-market trading after the company applied for a patent for vaccines targeting Neisseria gonorrhoeae.
Evaxion Biotech shares jumped 62% to $1.37 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
Losers
Now Read This:
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
